About Us

私たちについて

This page serves as an overview of EVerMed’s vision and foundation.
Here, you will find our mission, leadership team, and partnership approach — the core elements that drive our innovation in extracellular vesicle medicine.

TOP

ABout Us

Extracellular vesicles (EVs) are gaining global attention as a next-generation pharmaceutical modality. We are actively engaged in the research and development of not only “naive” EVs secreted by natural cells but also engineered EVs—modified to provide targeted delivery and encapsulated therapeutic payloads.

Our core strength lies in our world-leading EV manufacturing technologies and our proprietary base of EV-producing cells. By leveraging this platform, we are committed to the continuous creation of innovative EV-based therapies.

Our Mission

Extracellular vesicles (EVs) are emerging as a transformative therapeutic modality, characterized by their intrinsic multi-target biological activity and versatility in engineering.

At EVerMed, we pursue a dual mission: to advance high-impact EV-based pipelines addressing unmet medical needs, and to build the technological infrastructure necessary for scalable, industrialized EV therapeutics.

Our goal is to establish EV medicine as a major pharmaceutical platform of the future.

Members

EVerMed is led by internationally recognized experts in extracellular vesicle biology, translational research, and pharmaceutical strategy.

Our team combines deep academic excellence with extensive industry experience in drug development and regenerative medicine.

This integrated leadership structure enables us to bridge fundamental science with clinical and commercial realization.

Partnerships

We actively collaborate with academic institutions, pharmaceutical and biotechnology companies, and strategic capital partners to advance the frontier of EV therapeutics.

Through joint research, pipeline licensing, and co-development initiatives, we aim to accelerate translation from mechanistic discovery to clinical application.

Together, we seek to build a sustainable ecosystem for next-generation EV medicine.

Get in Touch with Our Team

Examples of Inquiries

  • Collaboration or joint research opportunities
  • Technology evaluation or licensing inquiries
  • Partnership discussions with pharma companies
  • Investor or business development inquiries
  • Requests for scientific data or technical information